Search Videos and More
News
Temple Health Launches New Fox Chase-Temple Urologic Institute
Fox Chase Cancer Center and Temple Health are pleased to announce the new Fox Chase-Temple Urologic Institute, a groundbreaking initiative that will concentrate on both benign and oncologic urology. With over 20 urologists on faculty, the Institute will provide services at multiple locations throughout the greater Philadelphia area.
Course
New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings
This symposium will provide attendees with cutting-edge updates and perspectives on new diagnostic tools and management options of hematologic malignancies including genetic profiling, cytogenetics, molecular diagnostics, riskadaptive strategies, and novel therapies recently approved by the FDA.
News
Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
News
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment
Could NanoKnife be the future of prostate cancer care?
News
A Salvage Treatment Jennifer Was Inspired to Salvage.
A Life-Saving Idea for Bladder Cancer Patients.
News
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment
Bladder removal is life-altering. This study examines when and why some patients may not need it.
Symposium
Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer
View this symposium presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. Learn the most current strategies for optimally managing localized and advanced prostate cancer from the Fox Chase Cancer Center genitourinary oncology team—nationally recognized physicians specializing in urology, radiation therapy, medical oncology, and radiology
Symposium
21st Annual Highlights of the 2022 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, these enduring materials help clinicians translate the data from key presentations from the 2022 San Antonio Breast Cancer Symposium into practice. View speakers from Fox Chase and Penn Medicine’s Abramson Cancer Center as they present information on the treatment of breast cancer, including screening, prevention, local control, chemotherapy, hormonal therapy, and advances in breast cancer biologics and their impact on breast cancer management.
Symposium
Management of Early Stage Non-Small Cell Lung Cancer
This conference was presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education. It was designed as a forum for discussion of advances in technology and treatment of early stage non-small cell lung cancer. Multidisciplinary perspectives, including medical, surgical and radiation oncology, pulmonology, and radiology.
News
A More Accurate, Less Invasive Analysis for Lung Cancers: RNA Next-Generation Sequencing
Genetically targeted therapy for lung cancer can make treatment much more effective, but identifying the specific gene fusions involved in the disease remains a challenge.
News
Bispecifics: A Molecular Missile That Labels Cancer Cells and Kills Them
A relatively new classification of immunotherapeutic drugs is pushing the outer limits of late-line treatment, bringing new hope to patients and the cancer community. They’re bispecific antibodies.
News
Cancer Is a Moving Target.
CBCT-Based Adaptive Radiation Therapy Tracks It Every Day of Treatment.